Karyopharm Therapeutics To Present At The Oppenheimer 24th Annual Healthcare Conference

NATICK, Mass., Dec. 5, 2013 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, announced today that Michael Kauffman, Chief Executive Officer, will present at the Oppenheimer 24th Annual Healthcare Conference on Wednesday, December 11, at 2:45 p.m. ET. The conference is being held at the Crowne Plaza Times Square in New York.

Help employers find you! Check out all the jobs and post your resume.